Biden sets ambitious goals at COVID summit

US President Joe Biden’s plans face a tough road as pressure grows for big pharmaceutical companies to share their vaccine technologies with poorer nations that are scrambling for doses of the lifesaving COVID vaccine

President Joe Biden, declaring the coronavirus an “all-hands-on-deck crisis,” set out ambitious goals Wednesday for ending the pandemic and urged world leaders, drug companies, philanthropies and non-profit groups to embrace a target of vaccinating 70% of the world by next year. But the course that Biden charted, at a virtual COVID-19 summit meeting that he convened on the sidelines of the U.N. General Assembly in New York, may be difficult to turn into reality. And pressure is mounting on the president to lean harder on U.S. pharmaceutical manufacturers, which are resisting sharing their COVID-19 technology with poorer countries.

The day-long meeting, the largest gathering of heads of state to address the pandemic, was a reflection of Biden’s determination to reestablish the United States as a leader in global health after President Donald Trump severed ties with the World Health Organization last year, at the outset of the coronavirus crisis.

Biden announced a series of actions, including the purchase of an additional 500 million doses of Pfizer’s vaccine at a not-for-profit price to donate overseas and $370 million to administer the shots. Vice President Kamala Harris announced that the United States would donate $250 million to a new global fund that aims to raise $10 billion to prevent future pandemics. “We’re not going to solve this crisis with half-measures or middle-of-the-road ambitions. We need to go big,” the president said in televised remarks. “And we need to do our part: governments, the private sector, civil society leaders, philanthropists.”

Still, Biden’s summit meeting spurred some resentment toward the United States from those who have criticised the administration for hoarding vaccines and not doing enough to help developing nations manufacture their own. Others said the administration was claiming credit for a plan that already existed. “It’s not really new, but the financial power of what they put on the table is new of course,” Dr. Marie-Paule Kieny, a French virus expert and former top WHO official, said in an interview. She noted that the organisation had already set a target of vaccinating 70% of people in low- and middle-income countries by next September.

“The U.S. wants to be engaged,” she added, “but they still don’t know exactly how to engage with the new world that has developed while they were away.” Biden also faces criticism for offering booster doses to fully vaccinated Americans when millions of people around the world, including health care workers, have yet to receive a first dose. In his speech at the United Nations on Wednesday, President Uhuru Kenyatta of Kenya said that such inequities were hindering efforts to rebuild the global economy, which requires confidence and investment.

“The surest way to building that confidence is by making vaccines available to the world, in an equitable and accessible manner,” Kenyatta said. “That, sadly, is currently not the case. The asymmetry in the supply of vaccines reflects a multilateral system that is in urgent need for repair.” More than 4.7 million people around the world, and more than 678,000 in the United States, have died of COVID-19 — a “global tragedy,” Biden said. While three-quarters of Americans have had at least one coronavirus shot, less than 10% of the population of poor nations — and less than 4% of the African population — has been fully vaccinated. Worldwide, 79% of shots that have been administered have been in high- and upper-middle-income countries, according to the Our World in Data project at the University of Oxford. COVAX, the WHO-backed international vaccine initiative, is behind schedule in delivering shots to low- and middle-income nations that need them the most. At a briefing held by Physicians for Human Rights this week, Dr. Soumya Swaminathan, chief scientist of the WHO, issued a plea for nations to work together to distribute vaccines in a coordinated and equitable way. She also urged countries to share their excess supplies.

“A country-by-country approach, a nationalistic approach, is not going to get us out of this pandemic,” she said. “And that’s where we are today.” Experts estimate that 11 billion doses are necessary to reach widespread global immunity. Before Wednesday, the United States had promised to donate more than 600 million doses. The additional 500 million that Biden pledged brings the total U.S. commitment to 1.1 billion doses, more than any other country. “Put another way, for every one shot we’ve administered to pay in America, we have now committed to do three shots to the rest of the world,” Biden said. But activists, global health experts and world leaders say donated doses will not be enough. They are calling for the Biden administration to do more to scale up global manufacturing of vaccines, particularly in Africa, where the need is greatest. “The COVID-19 pandemic reminds us of the importance of diversification of production centers across the world,” President Joko Widodo of Indonesia, which has suffered one of the biggest surges in cases, said in his General Assembly speech. “We know that no one is safe until everyone is.”

The landscape for getting shots into arms has become increasingly challenging since COVAX was created in April 2020. Some Asian countries have imposed tariffs and other trade restrictions on COVID-19 vaccines, slowing their delivery. India, home to the world’s largest vaccine-maker, has banned coronavirus vaccine exports since April, although officials say they will resume next month. In his opening remarks, Biden called on other wealthy nations to live up to their donation commitments. He also appeared to take a veiled shot at China, which did not participate in the summit, and has for the most part been selling — rather than donating — its vaccine to other countries. “We should unite around the world on a few principles: that we commit to donating, not selling — donating, not selling — doses to low- and lower-income countries, and that the donations come with no political strings attached,” the president said. He also announced a vaccine partnership with the European Union and said the United States was working to scale up production overseas through a partnership with India, Japan and Australia that was “on track to produce at least 1 billion vaccine doses in India to boost the global supply by the end of 2022.”

The doses the Biden administration is donating, however, have been trickling out slowly. So far, 157 million have been shipped overseas. Dr. Peter J. Hotez, an infectious disease expert at Texas Children’s Hospital who helped develop a coronavirus vaccine that is being manufactured in India, said the president should have laid out “a frank articulation of the magnitude” of the shortage. “We don’t need it by 2023,” Hotez said. “We need it now, over the next six to eight months.”